share_log
Moomoo 24/7 ·  Apr 1 08:36
Surrozen Announces Safety, Pharmacodynamic And Liver Function Data For SZN-043; Says Phase 1A Trial Demonstrated 'Acceptable' Safety And Tolerability With No Reported Serious Adverse Events
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment